CombinatoRx
A biotech company that develops medicines from synergistic combinations of approved drugs.
Launch date
Market cap
-
Enterprise valuation
$120—180m (Dealroom.co estimates Mar 2004.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$40.0m | Series B | ||
$30.0m | Series C | ||
N/A | Acquisition | ||
Total Funding | $70.0m |